| 2012 | | C-reactive protein is a more sensitive and specific marker for diagnosing bacterial infections in systemic lupus erythematosus compared to S100A8/A9 and procalcitonin | 김현아, 서창희, 전자영 |
| 2018 | | Central Nervous System Lupus During Pregnancy Accompanied by Hypothermia | 김행수, 김현아, 양정인, 임승관, 정바다 |
| 2018 | | Characteristic patterns of HLA presentation and T cell differentiation in adult-onset Still's disease | 김현아, 서창희, 손성향, 정주양 |
| 2017 | | Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab | 김현아, 서창희 |
| 2016 | | Circulating hsa-miR-30e-5p, hsa-miR-92a-3p, and hsa-miR-223-3p may be novel biomarkers in systemic lupus erythematosus | 김현아, 서창희, 정주양 |
| 2024 | | Clinical characteristics and prognostic factors of non-tuberculous mycobacterial disease in patients with rheumatoid arthritis | 김지원, 김현아, 서창희, 정주양 |
| 2019 | | Clinical characteristics and role of whole-body bone scan in multifocal osteonecrosis | 김현아, 박성훈, 서창희, 안영실, 정주양 |
| 2022 | | Clinical Characteristics of Patients With Psoriatic Spondylitis Versus Those With Ankylosing Spondylitis: Features at Baseline Before Biologic Therapy | 김현아 |
| 2022 | | Clinical Features and Drug Retention of TNF Inhibitors in Older Patients with Ankylosing Spondylitis: Results from the KOBIO Registry | 김지원, 김현아, 서창희, 정주양 |
| 2023 | | Comparative effectiveness of JAK inhibitors and biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis | 김현아 |
| 2017 | | Comparative effectiveness of treatment options after conventional DMARDs failure in rheumatoid arthritis | 김현아, 서창희 |
| 2018 | | Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial | 서창희 |
| 2016 | | Concordance between the tuberculin skin test and interferon gamma release assay (IGRA) for diagnosing latent tuberculosis infection in patients with systemic lupus erythematosus and patient characteristics associated with an indeterminate IGRA | 김현아, 서창희, 정주양 |
| 2022 | | Correlations between salivary gland scintigraphy and histopathologic data of salivary glands in patients with primary Sjogren’s syndrome | 강정현, 김지원, 김현아, 노진, 서창희, 안영실, 정주양, 한재호 |
| 2017 | | Current gout treatment and flare in South Korea: Prophylactic duration associated with fewer gout flares | 김현아, 서창희 |
| 2006 | | Cysteinyl leukotriene receptor 1 promoter polymorphism is associated with aspirin-intolerant asthma in males. | 김승현, 남동호, 박해심, 서창희 |
| 2017 | | Determinants of quality of life in patients with fibromyalgia: A structural equation modeling approach | 김현아 |
| 2012 | | Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy | 김현아, 서창희 |
| 2019 | | Differences in Expression of Human Leukocyte Antigen Class II Subtypes and T Cell Subsets in Behcet's Disease with Arthritis | 김현아, 서창희, 손성향, 정주양 |
| 2021 | | Effectiveness and drug retention of biologic disease modifying antirheumatic drugs in Korean patients with late onset ankylosing spondylitis | 김현아 |
| 2021 | | Effectiveness and safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis: Real-world data from the KOBIO registry | 김현아 |
| 2023 | | Effects of COVID-19 and Influenza Vaccination on Rheumatic Diseases: Results From a Survey of Patient-Reported Outcomes After Vaccination | 김지원, 김현아, 서창희, 예영민, 정주양 |
| 2022 | | Effects of RETN polymorphisms on treatment response in rheumatoid arthritis patients receiving TNF-α inhibitors and utilization of machine-learning algorithms | 김현아, 정주양 |
| 2018 | | Effects of risk factors for and components of metabolic syndrome on the quality of life of patients with systemic lupus erythematosus: a structural equation modeling approach | 김현아 |
| 2019 | | Effects of tapering tumor necrosis factor inhibitor on the achievement of inactive disease in patients with axial spondyloarthritis: a nationwide cohort study | 김현아 |
| 2023 | | Efficacy and drug retention of tofacitinib in rheumatoid arthritis: from the nationwide Korean College of Rheumatology Biologics registry | 김지원, 김현아, 서창희, 정주양 |
| 2024 | | Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia | 서창희 |
| 2019 | | Efficacy and safety of mycophenolate mofetil and tacrolimus combination therapy in patients with lupus nephritis: a nationwide multicentre study | 서창희 |
| 2020 | | Efficacy and Safety of Rituximab in Korean Patients with Refractory Inflammatory Myopathies | 서창희 |
| 2017 | | Efficacy and Safety of Switching from Innovator Rituximab to Biosimilar CT-P10 Compared with Continued Treatment with CT-P10: Results of a 56-Week Open-Label Study in Patients with Rheumatoid Arthritis | 서창희 |
| 2019 | | Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial | 서창희 |
| 2016 | | Efficacy of tocilizumab therapy in Korean patients with adult-onset Still's disease: a multicentre retrospective study of 22 cases | 김현아 |
| 2017 | | Efficacy, Safety and Pharmacokinetics of Up to Two Courses of the Rituximab Biosimilar CT-P10 Versus Innovator Rituximab in Patients with Rheumatoid Arthritis: Results up to Week 72 of a Phase I Randomized Controlled Trial | 서창희 |
| 2022 | | Elevated expression of TLR2 and its correlation with disease activity and clinical manifestations in adult-onset Still’s disease | 권지은, 김지원, 김현아, 서창희, 임현이, 정주양, 한재호 |
| 2016 | | Elevated high-mobility group B1 levels in active adult-onset Still's disease associated with systemic score and skin rash | 김현아, 서창희, 손성향, 정주양 |
| 2015 | | Elevated Salivary Alpha-Amylase Level, Association Between Depression and Disease Activity, and Stress as a Predictor of Disease Flare in Systemic Lupus Erythematosus: A Prospective Case-Control Study. | 김현아, 서창희, 정주양 |
| 2021 | | Eubacterium rectale Attenuates HSV-1 Induced Systemic Inflammation in Mice by Inhibiting CD83 | 김현아, 서창희, 손성향, 유혜명, 정주양 |
| 2019 | | Evaluation of factors affecting the levels of physical activity in patients with rheumatoid arthritis: a cross-sectional study | 부선주, 서창희, 정주양 |
| 2022 | | Factors affecting quality of life in patients with rheumatoid arthritis in South Korea: a cross-sectional study | 김지원, 부선주, 서창희 |
| 2018 | | Factors associated with quality of life and functional disability among rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs for at least 6 months | 서창희 |
| 2015 | | FcγRIIB Gene Polymorphisms Are Associated with Disease Risk and Clinical Manifestations of Systemic Lupus Erythematosus in Koreans. | 김현아, 서창희, 정주양 |
| 2022 | | Flare of adult-onset Still’s disease following mRNA COVID-19 vaccination: a case report and review of literature | 김지원, 김현아, 서창희, 정주양 |
| 2021 | | Four-year follow-up of atherogenicity in rheumatoid arthritis patients: from the nationwide Korean College of Rheumatology Biologics Registry | 김현아 |
| 2003 | | Heterogeneity of IgE response to cefteram pivoxil was noted in 2 patients with cefteram-induced occupational asthma. | 남동호, 박해심, 서유진, 서창희, 최정희 |
| 2015 | | High-density genotyping of immune loci in Koreans and Europeans identifies eight new rheumatoid arthritis risk loci. | 서창희 |
| 2016 | | High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry | 서창희 |
| 2017 | | Highly Expression of CD11b and CD32 on Peripheral Blood Mononuclear Cells from Patients with Adult-Onset Still's Disease | 김현아, 서창희, 손성향, 정주양 |
| 2003 | | Horner's syndrome as an initial manifestation of Takayasu's arteritis. | 박해심, 서유진, 서창희, 최정희 |
| 2016 | | Hyponatremia in patients with systemic lupus erythematosus | 박세진, 서창희 |
| 2016 | | Identification of a Systemic Lupus Erythematosus Risk Locus Spanning ATG16L2, FCHSD2, and P2RY2 in Koreans | 서창희 |
| 2017 | | Identifying fibromyalgia subgroups using cluster analysis: Relationships with clinical variables | 김현아 |
| 2016 | | Impact of Childbearing Decisions on Family Size of Korean Women with Systemic Lupus Erythematosus | 김현아, 서창희 |
| 2020 | | Impact of immunogenicity on efficacy and tolerability of tumour necrosis factor inhibitors: pooled analysis of biosimilar studies in rheumatoid arthritis | 서창희 |
| 2016 | | Imputing Variants in HLA-DR Beta Genes Reveals That HLA-DRB1 Is Solely Associated with Rheumatoid Arthritis and Systemic Lupus Erythematosus | 서창희 |
| 2015 | | Incomplete clearance of apoptotic cells in systemic lupus erythematosus: pathogenic role and potential biomarker. | 서창희, 정주양 |
| 2023 | | Increased Immunoglobulin Gamma-3 Chain C in the Serum, Saliva, and Urine of Patients with Systemic Lupus Erythematosus | 김지원, 김현아, 백욱영, 서창희, 정주양 |
| 2004 | | Increased levels of IgG to cytokeratin 19 in sera of patients with toluene diisocyanate-induced asthma. | 김승현, 남동호, 박해심, 서창희 |
| 2012 | | Induction of remission is difficult due to frequent relapse during tapering steroids in Korean patients with polymyalgia rheumatica | 김현아, 서창희 |
| 2017 | | Infection in systemic lupus erythematosus, similarities, and differences with lupus flare | 서창희, 정주양 |
| 2010 | | Interleukin 6 gene polymorphisms are associated with systemic lupus erythematosus in Koreans. | 김승현, 김현아, 박해심, 서창희 |
